For more than a decade, Peter Zandstra has been working at the University of Toronto to rev up the production of stem cells and their descendants. The raw materials are adult blood stem cells and embryonic stem cells. The end products are blood and heart cells – lots of them. Enough mouse heart cells that they form beating tissue.
To do this, he has been applying engineering principles to stem cell research – work that has just earned him recognition by the American Association for the Advancement of Science (AAAS). The society will induct him as a Fellow during its Annual Conference, being held in Boston from February 14 to 18.
Starting with computer models of stem cell growth and differentiation (the process by which a stem cell matures into its final form), Zandstra has moved on to develop more sophisticated culture methods that fine-tune the microenvironments to guide the generation of the different cells types that make up the mature cells in our tissues: heart cells for the heart or blood cells for blood.
"If you describe something mathematically, you have a much better understanding of it than if you just observe it," he says. "And it's also a powerful way to test many different hypotheses in silico before going into the lab and doing the much more difficult experiments in vitro."
Dr. Zandstra, the Canada Research Chair in Stem Cell Bioengineering, also held a prestigious NSERC Steacie Fellowship. The Steacie prize - which goes to six select Canadian professors annually – allowed Zandstra to extend his work from mouse to man.
“There's only so much we can do with mouse cells,” notes Dr. Zandstra. “Now if we can also figure out how to get human embryonic stem cells to differentiate on command to generate functional adult-like cells, you can begin to think about the kinds of medical conditions you could treat with them.”
Source: Natural Sciences and Engineering Research Council
Related stories:
What's good for the mouse is good for the monkey: Skin cells reprogrammed into stem cells
Scientists have successfully created the first induced pluripotent stem (iPS) cell lines from adult monkey skin cells. The research, published by Cell Press in the December issue of the journal
Cell Stem Cell, demonstrates that the method of direct reprogramming is conserved among species and may be useful for creation of clinically valuable primate models for human diseases.
Scientists prove endothelial cells give rise to blood stem cells
Stem cell researchers at UCLA have proven definitively that blood stem cells are made during mid-gestational embryonic development by endothelial cells, the cells that line the inside of blood vessels.
A Novel Human Stem Cell-based Model of ALS Opens Doors for Rapid Drug Screening
Long thought of as mere bystanders, astrocytes are crucial for the survival and well-being of motor neurons, which control voluntary muscle movements. In fact, defective astrocytes can lay waste to motor neurons and are the main suspects in the muscle-wasting disease amyotrophic lateral sclerosis (ALS).
Scientists probe limits of 'cancer stem-cell model'; Melanoma does not fit the model
(PhysOrg.com) -- One of the most promising new ideas about the causes of cancer, known as the cancer stem-cell model, must be reassessed because it is based largely on evidence from a laboratory test that is surprisingly flawed when applied to some cancers, University of Michigan researchers have concluded.
New 'control knobs' for stem cells identified
Natural changes in voltage that occur across the membrane of adult human stem cells are a powerful controlling factor in the process by which these stem cells differentiate, according to research published by Tufts University scientists.
Study raps Web sites touting stem cell therapies
(AP) -- Consumers should be wary of Web sites from clinics that offer stem cell treatments, says a study that found a lack of firm medical evidence to back up their claims.
What makes the heart 'tick-tock'
Researchers have new evidence to show that the heart beats to its own drummer, according to a report in the December issue of the journal
Cell Metabolism. They've uncovered some of the molecular circuitry within the cardiovascular system itself that controls the daily rise and fall of blood pressure and heart rate. The findings might also explain why commonly used diabetes drugs come with cardiovascular benefits, according to the researchers.
Mapping brain cancer to find best treatment
There's never a good time to have brain cancer. Still, Karl DuBose tries to look on the bright side. "It's weird to say, but today - and here in Seattle - might be the best time and place to get this disease," said the 45-year-old Everett, Wash., man, who was slammed with the diagnosis last summer.